CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot offers hope for controlling tough liver virus
Disease control OngoingThis study is testing a new drug called BJT-778 (brelovitug) for people with chronic Hepatitis D, a serious liver infection. About 150 participants will either start the weekly or monthly injections right away or wait 24 weeks before beginning treatment. The main goal is to see i…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Tracking Real-World results for hepatitis d treatment
Disease control OngoingThis study collects long-term safety and effectiveness data from people with chronic hepatitis D who are being treated with bulevirtide. It follows 170 participants who are either already receiving the medication or are scheduled to start treatment. The main goal is to monitor li…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC